News You Can Use… Pete Koval, PharmD Lauren Bajbus, PharmD Cone Health Family Medicine July 2014.

Slides:



Advertisements
Similar presentations
Inhaled Human Insulin and its Place in Therapy
Advertisements

General Pharmacology Chapter 10. General Pharmacology You will be responsible for administering certain drugs. You will be responsible for assisting patients.
News You Can Use… Pete Koval, PharmD Megan Radigan, PharmD Candidate Kira Letvak, PharmD Candidate Cone Health Family Medicine May 2015.
News You Can Use… Pete Koval, PharmD Lauren Hickman, PharmD Candidate Cone Health Family Medicine April 2015.
Michael Rollins, PharmD Candidate Cone Health Family Medicine
News You Can Use… Pete Koval, PharmD Alvin Oung, PharmD Cone Health Family Medicine March 2015.
News You Can Use… Lauren Gray, PharmD Candidate February 2015.
News You Can Use… Pete Koval, PharmD Laura Evington, PharmD candidate Cone Health Family Medicine November 2014.
Sivextro™ (tedizolid phosphate)
News You Can Use… Pete Koval, PharmD Kim Mitchell, PharmD candidate Cone Health Family Medicine October 2014.
Cone Health Family Medicine
News You Can Use… Jessica Binz, PharmD Pete Koval, PharmD Cone Health Family Medicine September 2014.
Pramlintide Advisory Committee July 26, 2001 Symlin ® Amylin Pharmaceuticals New Drug Application (21-332) Advisory Committee Meeting Bethesda, Maryland.
Afrezza® – inhaled human insulin
Megan Shah, PharmD Candidate Cone Health Family Medicine
Pharmacists’ Expanded Scope of Practice in Canada as of Oct 2014 Source: Canadian Pharmacists Association.
Medication Options H ealthPLACE/HOPE Program COPYRIGHT © 2002 Highmark Inc. All Rights Reserved. These materials may not be copied or otherwise reproduced.
News You Can Use… Pete Koval, PharmD Tiffany Wong, PharmD Candidate Cone Health Family Medicine June 2014.
Consider this Combo: GLP-1 Receptor Agonists and Basal Insulin Matt Heinsen, PharmD PGY2 Pharmacotherapy Resident Butler University & Community Health.
Saxenda (Liraglutide) SAMUEL GYAWU-AMOATENG. Indication & Approval  Saxenda, is FDA approved as a treatment option for chronic weight management in addition.
News You Can Use… Pete Koval, PharmD Christina Adler, PharmD candidate Cone Health Family Medicine December 2014.
A New Modality for Treating Type 2 Diabetes
Drugs in the Body (1) Recurrence Relations A patient is given an initial dose of 50mg of a drug. Each hour the patient is given a 20mg tablet of the.
Cystic Fibrosis Afshaun Haniff, PharmD Candidate
Toujeo® and it’s Place in Therapy
POSTER TEMPLATE BY: Long Acting Insulin for the Treatment of Diabetes Mellitus Kim Tran, Eric Tang, Randa Rifai, Udo Oji Touro.
News You Can Use… Stacey Karl, PharmD Pete Koval, PharmD Cone Health Family Medicine August 2015.
Endocrine and Metabolic Disorders Lectures 8 I.Kuziv, MD, PhD.
Tommi Cooke, PharmD Candidate 2016 Cone Health Family Medicine
News You Can Use… Josh Stewart, PharmD Candidate 2016 Pete Koval, PharmD Cone Health Family Medicine October 2015.
New CRM Paradigm Precision Adherence. Patients don’t take their drugs 32 million Americans use three or more medicines daily. 75% of adults are non-adherent.
Pharmacology Basics Presentation Name Course Name
10: General Pharmacology
News You Can Use… Nick Gazda, PharmD Candidate 2016 Pete Koval, PharmD Cone Health Family Medicine December 2015.
Drugs Health 12. What is a drug? Substance other than food that changes the way the body or the mind functions Correct use of legal drugs to promote well-being.
News You Can Use… Stacey Karl, PharmD Pete Koval, PharmD Cone Health Family Medicine January 2016.
Persida Tahiri, PharmD Candidate 2016 Cone Health Family Medicine
AUGUST Is a blend of dry botanical extracts, mixed in honey and date syrup. Each botanical extract has been authorized and defined by the Israeli.
Understanding Drugs and Medications What are drugs? Where do drugs come from? What are the different kinds of drugs and medicines? How do they enter the.
Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 36 Calculation of Medication Dosage and Medication Administration.
News You Can Use… Phillip Transou, PharmD Candidate Pete Koval, PharmD Cone Health Family Medicine June, 2016.
News You Can Use… Megan Supple, PharmD Pete Koval, PharmD Cone Health Family Medicine March 2016.
News You Can Use… Kristen Gray, PharmD Pete Koval, PharmD Cone Health Family Medicine April 4 th, 2016.
News You Can Use… Ethan Hammer, PharmD Candidate Pete Koval, PharmD Cone Health Family Medicine August, 2016.
News You Can Use… Simone Carden, PharmD Candidate Pete Koval, PharmD Cone Health Family Medicine July, 2016.
News You Can Use… Robert Vincent, PharmD PGY1 Pete Koval, PharmD Cone Health Family Medicine September, 2016.
Claudia Ortiz Lopez, PharmD Candidate Cone Health Family Medicine
Cone Health Family Medicine
Adam Corey, PharmD Candidate Cone Health Family Medicine
Claudia Ortiz Lopez, PharmD Candidate Cone Health Family Medicine
Rachel Kim, PharmD Candidate Cone Health Family Medicine
2012 ADA Clinical Practice Guidelines Therapies for DM- Type 2
Claudia Ortiz Lopez, PharmD Candidate Cone Health Family Medicine
Patrick Kurunwune, PharmD Candidate Cone Health Family Medicine
Cone Health Family Medicine
Meredith Tilley, PharmD Candidate Cone Health Family Medicine
A Primer on Medication Delivery Systems in COPD Management
A Primer on Medication Delivery Systems in COPD Management
Range of mean changes from baseline in A1C in clinical studies of 24–52 weeks’ duration reported in prescribing information for five GLP-1 receptor agonists.
Presentation transcript:

News You Can Use… Pete Koval, PharmD Lauren Bajbus, PharmD Cone Health Family Medicine July 2014

New Drug Approval Dalvance (dalbavancin) received FDA approval for IV use in the treatment of MRSA skin and soft tissue infections Course of therapy would require 2 doses given 1 week apart 6/4/2014 FDA News & Events

New Drug Approval Sivextro (tedizolid) - approved for skin and soft tissue infections caused by MRSA IV and PO formulations will be available Daily dosing x 6 days 6/20/2014 Bloomberg News

New Drug Approval Afrezza (insulin human) inhalation powder approved for use in adults with diabetes Rapid-acting orally inhaled insulin Administered at the beginning of each meal 6/27/2014 FDA News & Events

New Drug Approval Jublia (efinaconazole) approved for the treatment onychomyosis of the toenail 10% topical solution Apply once daily to clean dry toenails. Wait for at least 10 minutes after showering, bathing, or washing before applying. Use for weeks… 6/12/2014 FDA News & Events

New Drug Approval Nasocobal (B12 supplementation nasal spray) approved by FDA Single-use devices for which the dosing is 500mcg (one spray) once weekly New DEVICE… “ our new single-use device does NOT require priming…eliminates product loss…permits patients to conveniently receive their dose with one spray per disposable device” 6/11/2014 Drug Store News

New Generic Approval Actonel (risdendronate sodium) 150mg Mylan will begin marketing this new generic 6/11/2014 Drug Store News

New Clinical Findings Around 30% of patients taking an OTC PPI are not taking them correctly (ie before breakfast) and are not achieving benefit Survey of 610 patients 190 received prescriptions from GI- 71% used correctly 223 received prescriptions from PCP- 47% used correctly 197 purchased OTC- 39% used correctly American Journal of Gastroenterology. 2014; 109:

New Clinical Finding Metformin may benefit African Americans more than “European Americans” A1c percentages decreased more in African American individuals Unsure if this translates to less complications from diabetes 6/12/2014 Journal of Clinical Endocrinology and Metabolism